29 February - 01 March 2024 | London, UK
Biomarkers 2024
29 February - 01 March 2024 | London, UK
Europe’s flagship event for Biomarker Research Returns: the must-attend forum to engage with the latest trends transforming biomarker and translational research

Biomarkers 2024, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.

It includes over 90 cutting-edge presentations and discussion sessions, 8+ hours of valuable networking sessions and an exhibition hall showcasing 50+ vendor companies.

18th Annual Biomarkers Congress

Benefits to Attending...

  • Hear from and meet with the key industry and academic innovators in biomarkers, translational medicine, clinical development and diagnostics
  • Discover the latest integration of biomarkers in drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, NASH and immunology
  • Gain novel insights into key biomarkers for detection, monitoring and diagnosis, including innovative applications of digital markers. Further talks look at early detection of cancer
  • Discuss the use of biomarkers in preclinical and clinical development: trial design & data analysis, assay development, patient stratification & selection and the role of safety & efficacy markers
  • Maximise your experience with our fully featured Event App, with selected presentations available to watch on-demand and extensive networking features
  • Benefit from a highly interactive event programme, with a selection of panels, workshops and roundtables on key areas for discussion within the industry

Agenda at a Glance

Day One 

  • Gain insights into the latest biomarker tools and applications within oncology and immunology 
  • Workshop: Biomarker Analysis workshop  
  • Diagnostic development: companion, tissue & PoC 
  • Early detection strategies 
  • Regulatory updates within Clinical Development 
  • Case studies of liquid biopsy applications 
  • Safety & efficacy biomarkers and translational strategies 
  • Implementing clinical biomarkers in immunology, oncology, cardiology, neuroscience and inflammatory diseases 
  • Panel Discussion: Reflection When Biomarker Development Fails And Lessons Learnt in Pre-Clinical Development 
  • Overcoming challenges in image analysis 
  • Imaging technologies, CNS imaging techniques and digital pathology 

Day Two

  • Case studies in biomarker discovery and validation in neuroscience and 
  • Insights into emerging modalities, including cell & gene therapies and rare disease 
  • Multiplexing technologies, Flow cytometry and Mass spectrometry
  • Immunoassays and screening processes
  • Assay development & validation 
  • Transforming clinical development through biomarker driven clinical trial design 
  • Patient Centric Biomarkers in Clinical Trials  
  • Precision medicine approaches 
  • Biofluid-based molecular biomarkers: ctDNA and CTCs 
  • Predictive and prognostic biomarkers for oncology and rare diseases  
  • Developing genomic biomarker assays for cancer, including PCR and miRNA technologies  

Key Speakers

The 2024 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below are some of the confirmed speakers for Biomarkers 2024.

Senior Vice President Clinical Development
Hummingbird Bioscience
Associate Director of Human Genomics
C4X Discovery
Director, Translational Research
Global Head Biomarkers & Clinical Bioanalyses
Senior Regulatory Affairs Director

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception

Event App

Our Event App features a personalisable agenda, peer-to-peer networking, OnDemand Presentations, solution provider content, and much more!

Holders of Oxford Global PLUS Pass have access to exclusive features on-site at the event:

…as well as year round access to our online member platform that contains industry insights, interviews with KOLs, regular themed discussion groups, peer to peer networking and much more.

Thank you to our Sponsors

Oxford Global Conferences | Protavio
Network & Programme Sponsor
Oxford Global Conferences - Precision For Medicine
Network & Programme Sponsor
Oxford Global Conferences | Novigenix
Network & Programme Sponsor
Oxford Global Conferences | Concept Life Sciences
Network & Programme Sponsor
Oxford Global Conferences | Quanterix
Bronze Sponsor
Oxford Global Conferences | Q2 Solutions
Bronze Sponsor
Oxford Global Conferences | Proteome Sciences
Bronze Sponsor
Oxford Global Conferences | Biognosys
Bronze Sponsor
Oxford Global Conferences | Aspect Analytics
Bronze Sponsor
Oxford Global Conferences | Alliance Pharma
Bronze Sponsor
Oxford Global Conferences | Almac
Silver Sponsor
Oxford Global Conferences | ARC Regulatory
Silver Sponsor
Silver Sponsor
Oxford Global Conferences | Canopy Biosciences
Silver Sponsor
Oxford Global Conferences | Somalogic
Gold Sponsor
Oxford Global Conferences | Sengenics
Gold Sponsor
Oxford Global Conferences | Sapient Bioanalytics
Gold Sponsor
Oxford Global Conferences | Personalis
Gold Sponsor
Oxford Global Conferences | Labcorp
Gold Sponsor
Oxford Global Conferences | NanoString Technologies
Diamond Sponsor
Oxford Global Conferences | Merck Life Science KGaA
Network & Programme Sponsor

Free Live Webinar

Development and Implementation of Flow Cytometry Assays for Use In Clinical Trials

Thursday 21st May | 3:30pm BST

Hosted by Nicholas Jones,
Director of Global Flow Cytometry – Pharma Services, NeoGenomics Laboratories